435 related articles for article (PubMed ID: 15210473)
1. Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
Aranda J; Hoang MP; Cohen JB
Arch Dermatol; 2004 Jun; 140(6):751-6. PubMed ID: 15210473
[No Abstract] [Full Text] [Related]
2. Combined therapy of leprosy in Bhutan.
Samuel NM; Samuel S
Indian J Lepr; 1984; 56(3):647-52. PubMed ID: 6549335
[No Abstract] [Full Text] [Related]
3. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
4. [Combination chemotherapy in leprosy].
Leiker DL
Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
[No Abstract] [Full Text] [Related]
5. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
6. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
Martinez Cruz D
Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
[No Abstract] [Full Text] [Related]
7. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Winsley BE; McDougall AC; Brown KE
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
[No Abstract] [Full Text] [Related]
9. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
10. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
11. [Combination drug therapy in leprosy].
Terencio de las Aguas J
Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802
[TBL] [Abstract][Full Text] [Related]
12. [Field experiences with therapy protocols in leprosy].
Pattyn SR
Verh K Acad Geneeskd Belg; 1983; 45(3):303-14. PubMed ID: 6364614
[No Abstract] [Full Text] [Related]
13. Painless Nodular Rash in a Young Man.
Bass M; Foster K; Studdiford J
Am Fam Physician; 2017 Aug; 96(3):189-190. PubMed ID: 28762689
[No Abstract] [Full Text] [Related]
14. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
15. New approaches to chemotherapy for leprosy.
Waters MF
Drugs; 1983 Dec; 26(6):465-7. PubMed ID: 6653446
[No Abstract] [Full Text] [Related]
16. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
[TBL] [Abstract][Full Text] [Related]
18. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
[TBL] [Abstract][Full Text] [Related]
19. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Lockwood DN; Cunha Mda G
Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
[No Abstract] [Full Text] [Related]
20. Leprosy.
Indian J Med Sci; 1997 Dec; 51(12):482. PubMed ID: 9715550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
